Intracellular location of the early steps of the isoprenoid biosynthetic pathway in the trypanosomatids Leishmania major and Trypanosoma brucei.
The isoprenoid biosynthetic pathway is a very complex route that entails multiple steps and generates a high number of end-products that are essential for cell viability such as sterols, dolichols, coenzyme Q, heme and prenylated proteins. In parasites from the Trypanosomatidae family this pathway provides new potential drug targets for exploitation in the search for improved therapies, and indeed compounds such as ketoconazole, aminobisphosphonates or terbinafine have been shown to have antiprotozoal activity both in vitro and in vivo. However, despite the high therapeutic importance of the pathway, the subcellular compartmentalization of the different steps of isoprenoid biosynthesis is not known in detail. Here we have analysed the intracellular location of the enzymes 3-hydroxy-3-methyl-glutaryl Coenzyme A (HMG-CoA) synthase (HMGS) and mevalonate kinase (MVAK) in Leishmania major promastigotes as well as in Trypanosoma brucei procyclic and bloodstream forms. For this purpose we generated specific polyclonal antibodies against both highly purified recombinant proteins and used those in indirect immunofluorescence and digitonin titration experiments. Results show that sterol biosynthesis is distributed in multiple intracellular compartments and provide evidence indicating that in trypanosomatids the production of HMG-CoA from acetyl Coenzyme A and generation of mevalonate occur mainly in the mitochondrion while further mevalonate phosphorylation is almost exclusively located in glycosomes. Furthermore, we have determined that peroxin 2 (PEX2) is involved in efficient targeting of MVAK and that the enzyme is relocated to the cytosol upon depletion of this peroxin involved in glycosomal matrix protein import.
Instituto de Parasitología y Biomedicina López-Neyra, Parque Tecnológico de Ciencias de la Salud, Consejo Superior de Investigaciones Científicas, Granada, Spain.
Juana
J
Carrero-Lérida
Guiomar
G
Pérez-Moreno
Victor M
VM
Castillo-Acosta
Luis M
LM
Ruiz-Pérez
Dolores
D
González-Pacanowska
D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology; D053898:Biosynthetic Pathways; D004072:Digitonin / Q000737:chemistry; D005455:Fluorescent Antibody Technique; D006801:Humans; D006904:Hydroxymethylglutaryl-CoA Synthase / Q000378:metabolism; D018320:Leishmania major / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D007896:Leishmaniasis / Q000378:metabolism / Q000469:parasitology*; D008830:Microbodies / Q000378:metabolism*; D008928:Mitochondria / Q000378:metabolism*; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000378:metabolism; D021381:Protein Transport; D015800:Protozoan Proteins / Q000378:metabolism; D011817:Rabbits; D013729:Terpenes / Q000378:metabolism*; D014346:Trypanosoma brucei brucei / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D014353:Trypanosomiasis, African / Q000378:metabolism / Q000469:parasitology*
D000913:Antibodies, Protozoan; D015800:Protozoan Proteins; D013729:Terpenes; D006904:Hydroxymethylglutaryl-CoA Synthase; D017853:Phosphotransferases (Alcohol Group Acceptor); C021796:mevalonate kinase; D004072:Digitonin